All Employment articles – Page 6
-
Business
Job cuts at Allergan and Transgene
Allergan is shedding 300 staff at former Actavis site in Iceland, while Transgene is closing its French manufacturing plant with loss of 120 jobs
-
BusinessBMS sues executive for joining rival company
Bristol-Myers Squibb’s lawsuit against its former immuno-oncology chief who left to work for AstraZeneca has implications for biopharma industry
-
Business
Takeda to consolidate vaccines business in Boston
Firm will close three recently-acquired US sites and shift operations to the growing pharmaceutical hub in Massachusetts
-
Business
Zoetis to sell or close 10 plants in cost-cutting drive
Animal health firm will slash product portfolio in a bid to save $300m annually
-
Business
Dow to shed up to 1750 jobs by 2017
Chemical giant will lay off about 3% of its global workforce in the next two years
-
Business
Amgen to axe 300 Onyx employees
Amgen will close its Onyx facility in South San Francisco in December
-
Business
Mergers and moves trigger pharma layoffs
Shire expects to sack 500 or more employees, while Merck and GSK also wield the axe
-
Business
AstraZeneca to spin off anti-infectives research
Early-stage research will transfer to a new company, while AZ and MedImmune retain late-stage programmes
-
-
-
Business
Huntsman looks to cut jobs and titania capacity
900 employees face axe as firm evaluates titanium dioxide options
-
BusinessGSK cuts US jobs in push for savings
Research Triangle Park site bears the brunt as drugmaker consolidates research in Philadelphia and Stevenage, UK
-
Business
Syngenta to cut or relocate 1800 jobs in 2015
Global reorganisation plan will involve ‘consolidation’ of R&D facilities
-
Business
Lanxess to cut 1000 jobs over two years
Agrium also cutting 500 positions and divesting underperforming business segments
-
Business
Chinese buyer resurrects US Boehringer plant
UniTao will take over manufacturing site scheduled for closure, saving over 200 jobs
-
BusinessCHF3bn redevelopment for Roche’s Basel site
New buildings will move employees out of rented office space
-
Business
Amgen stacks up additional job cuts
Up to 1100 more staff face redundancy in ongoing restructuring plan
-
Business
Agilent to exit NMR
Closure of loss-making ex-Varian business gives users investment dilemma
-
Business
Novo Nordisk quits inflammation R&D and cuts jobs
Firm will return to primary focus on diabetes and obesity